Refining Risk Assessment in Women With Benign Breast Disease: An Ongoing Dilemma

Affiliations

¹ Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
² Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
³ Hematology-Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.

Comment

Stuart J Schnitt et al. J Natl Cancer Inst. 2017.

. 2017 Oct 1;109(10).

doi: 10.1093/jnci/djx036.

¹ Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
² Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
³ Hematology-Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.

No abstract available

Comment on

Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies.
Visscher DW, Frank RD, Carter JM, Vierkant RA, Winham SJ, Heinzen EP, Broderick BT, Denison LA, Allers TM, Johnson JL, Frost MH, Hartmann LC, Degnim AC, Radisky DC. Visscher DW, et al. J Natl Cancer Inst. 2017 Oct 1;109(10):djx035. doi: 10.1093/jnci/djx035. J Natl Cancer Inst. 2017. PMID: 28376198 Free PMC article.

Associations of fecal microbial profiles with breast cancer and nonmalignant breast disease in the Ghana Breast Health Study.
Byrd DA, Vogtmann E, Wu Z, Han Y, Wan Y, Clegg-Lamptey JN, Yarney J, Wiafe-Addai B, Wiafe S, Awuah B, Ansong D, Nyarko K, Hullings AG, Hua X, Ahearn T, Goedert JJ, Shi J, Knight R, Figueroa JD, Brinton LA, Garcia-Closas M, Sinha R. Byrd DA, et al. Int J Cancer. 2021 Jun 1;148(11):2712-2723. doi: 10.1002/ijc.33473. Epub 2021 Feb 26. Int J Cancer. 2021. PMID: 33460452 Free PMC article.